Clinical Trials Logo

Clinical Trial Summary

The biodegradable ABSORB scaffold is characterized by a greater strut thickness, but it has a greater flexibility compared to the XIENCE stent. Due to its fragility the inflating pressure of the ABSORB scaffold is limited and suitable lesions have to be well prepared. This study assesses the incidence of malapposed stent-struts, and the frequency of stent-underexpansion and edge dissection after ABSORB implantation compared to the XIENCE stent.


Clinical Trial Description

n/a


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT02001025
Study type Observational
Source Medical University of Vienna
Contact Daniel Dalos, MD
Phone +43 1 40400 4614
Email daniel.dalos@meduniwien.ac.at
Status Recruiting
Phase N/A
Start date November 2013